Javascript must be enabled to continue!
Research of the Process of Obtaining Monocalcium Phosphate from Unconditional Phosphate Raw Materials
View through CrossRef
The article presents methods for processing low-grade phosphate raw materials from the Chilisay deposit using a circulation method to produce mineral fertilizers and feed monocalcium phosphate. A study was conducted on the process of obtaining high-quality monocalcium phosphate, and optimal parameters for the decomposition of low-grade phosphate raw materials were determined. Based on the research, it was established that for the decomposition of phosphate raw materials, phosphoric acid with a concentration of 36–42% P2O5 should be used; the recycle phosphoric acid rate should be 540–560% of the stoichiometric amount required for the formation of monocalcium phosphate (MCP); the decomposition temperature should be 95–100 °C; the decomposition duration should be 40–50 min; the filtration temperature of the insoluble residue should be 85–90 °C; the crystallization temperature of MCP should be 40–45 °C; and the crystallization duration should be 85–90 min. For the sulfation of the mother solution and the production of recycle phosphoric acid, sulfuric acid with a concentration of 86–93% H2SO4 should be used; the sulfuric acid rate should be 95–100% of the stoichiometric amount required for the decomposition of dissolved Ca(H2PO4)2. After drying the wet residue, monocalcium phosphate was obtained with the following composition: P2O5—55%, Ca—18.01%, H2O—4.0%, F—0.01%, As—0.004%, Pb—0.002%. The obtained monocalcium phosphate is used in agriculture as a mineral fertilizer and feed monocalcium phosphate.
Title: Research of the Process of Obtaining Monocalcium Phosphate from Unconditional Phosphate Raw Materials
Description:
The article presents methods for processing low-grade phosphate raw materials from the Chilisay deposit using a circulation method to produce mineral fertilizers and feed monocalcium phosphate.
A study was conducted on the process of obtaining high-quality monocalcium phosphate, and optimal parameters for the decomposition of low-grade phosphate raw materials were determined.
Based on the research, it was established that for the decomposition of phosphate raw materials, phosphoric acid with a concentration of 36–42% P2O5 should be used; the recycle phosphoric acid rate should be 540–560% of the stoichiometric amount required for the formation of monocalcium phosphate (MCP); the decomposition temperature should be 95–100 °C; the decomposition duration should be 40–50 min; the filtration temperature of the insoluble residue should be 85–90 °C; the crystallization temperature of MCP should be 40–45 °C; and the crystallization duration should be 85–90 min.
For the sulfation of the mother solution and the production of recycle phosphoric acid, sulfuric acid with a concentration of 86–93% H2SO4 should be used; the sulfuric acid rate should be 95–100% of the stoichiometric amount required for the decomposition of dissolved Ca(H2PO4)2.
After drying the wet residue, monocalcium phosphate was obtained with the following composition: P2O5—55%, Ca—18.
01%, H2O—4.
0%, F—0.
01%, As—0.
004%, Pb—0.
002%.
The obtained monocalcium phosphate is used in agriculture as a mineral fertilizer and feed monocalcium phosphate.
Related Results
Cash‐based approaches in humanitarian emergencies: a systematic review
Cash‐based approaches in humanitarian emergencies: a systematic review
This Campbell systematic review examines the effectiveness, efficiency and implementation of cash transfers in humanitarian settings. The review summarises evidence from five studi...
Research of the Process of Obtaining Monocalcium Phosphate from Unconditional Phosphate Raw Materials
Research of the Process of Obtaining Monocalcium Phosphate from Unconditional Phosphate Raw Materials
In the chemical industry, one of the promising areas is the development of effective technologies for obtaining high-quality mineral fertilizers and feed mineral fertilizers from u...
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
Studi Kasus Penerapan Continuous Review Sistem (Q) dalam Manajemen Persediaan untuk Optimalisasi Biaya Produksi di UD. Indokarya Brass
Studi Kasus Penerapan Continuous Review Sistem (Q) dalam Manajemen Persediaan untuk Optimalisasi Biaya Produksi di UD. Indokarya Brass
UD. Indokarya Brass is a company engaged in the brass craft industry, UD. Indokarya Brass is located in Growong Lor Village, Juwana District, Pati Regency, Central Java Province. F...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...
Novel phosphate-based cements for clinical applications
Novel phosphate-based cements for clinical applications
This Thesis aims at the development of two novel families of inorganic phosphate cements with suitable characteristics for clinical applications in hard tissue regeneration or repl...
P0883HEALTHY FEMALES EXCRETE MORE PHOSPHATE THAN MALES IN RESPONSE TO AN ORAL CHALLENGE
P0883HEALTHY FEMALES EXCRETE MORE PHOSPHATE THAN MALES IN RESPONSE TO AN ORAL CHALLENGE
Abstract
Background and Aims
There are disparities in the diagnosis, treatment and prognosis for cardiovascular disease (CVD) be...

